<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4739</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2023.151001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	Antibacterial Activity of Silver, Gold and Amoxicillin-Silver Nanoparticles against Methicillin Resistant Staphylococcus aureus - an invitro Study&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>A</surname><given-names>Ramya K</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sanker</surname><given-names>Anu S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>S.</surname><given-names>Harish Kumar K.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Krishnan</surname><given-names>Shinu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Babu</surname><given-names>Neethu</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>05</month><year>2023</year></pub-date><volume>0)</volume><issue/><fpage>1</fpage><lpage>4</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: Methicillin-resistant staphylococcus aureus, a multi drug resistant bacterium is responsible for a broad spectrum of human and animal diseases ranging from skin infections to severe disorders as pneumonia, endocarditis and septicemia causing morbidity and mortality worldwide. This has led to growing interest in exploring novel methods to treat increasing drug resistance. Aim/Objectives: Aim of our study was to determine the anti-MRSA activity of silver and gold nanoparticles alone, also combination of amoxicillin and silver nanoparticles combination. Materials and Methods: The antimicrobial activity of silver and gold nanoparticles was evaluated using Disc diffusion method and amoxicillin in combination with silver nanoparticles by determining the colony forming units. Results: Silver nanoparticles showed anti-MRSA activity whereas gold nanoparticles, amoxicillin and silver nanoparticles combination showed no activity against MRSA clinical isolates.&#13;
&#13;
</p></abstract><kwd-group><kwd>Methicillin Resistant Staphylococcus aureus</kwd><kwd> Silver Nanoparticles</kwd><kwd> Gold Nanoparticles</kwd><kwd> Amoxicillin</kwd><kwd> Antibiotic Susceptibility Testing</kwd><kwd> Multi-Drug Resis</kwd></kwd-group></article-meta></front></article>
